Bronchorelaxation of the human bronchi by CFTR activators.

[1]  J. Mornon,et al.  C Terminus of Nucleotide Binding Domain 1 Contains Critical Features for Cystic Fibrosis Transmembrane Conductance Regulator Trafficking and Activation* , 2010, The Journal of Biological Chemistry.

[2]  D. Radzioch,et al.  Lack of CFTR in Skeletal Muscle Predisposes to Muscle Wasting and Diaphragm Muscle Pump Failure in Cystic Fibrosis Mice , 2009, PLoS genetics.

[3]  J. Hanrahan,et al.  Role of the cystic fibrosis transmembrane conductance channel in human airway smooth muscle. , 2009, American journal of respiratory cell and molecular biology.

[4]  C. Norez,et al.  A cystic fibrosis respiratory epithelial cell chronically treated by miglustat acquires a non-cystic fibrosis-like phenotype. , 2009, American journal of respiratory cell and molecular biology.

[5]  C. Guibert,et al.  Expression and function of cystic fibrosis transmembrane conductance regulator in rat intrapulmonary arteries , 2007, European Respiratory Journal.

[6]  J. Décout,et al.  Discovery of α-Aminoazaheterocycle-Methylglyoxal Adducts as a New Class of High-Affinity Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels , 2007, Journal of Pharmacology and Experimental Therapeutics.

[7]  C. Guibert,et al.  Evidence that CFTR is expressed in rat tracheal smooth muscle cells and contributes to bronchodilation , 2006, Respiratory research.

[8]  C. Norez,et al.  Disruption of CFTR chloride channel alters mechanical properties and cAMP‐dependent Cl− transport of mouse aortic smooth muscle cells , 2005, The Journal of physiology.

[9]  P. Woodruff,et al.  Structural changes to airway smooth muscle in cystic fibrosis , 2005, Thorax.

[10]  A. Kitzis,et al.  Regulation of the Cystic Fibrosis Transmembrane Conductance Regulator Channel by β-Adrenergic Agonists and Vasoactive Intestinal Peptide in Rat Smooth Muscle Cells and Its Role in Vasorelaxation* , 2004, Journal of Biological Chemistry.

[11]  R. Dérand,et al.  Synthesis, SAR, crystal structure, and biological evaluation of benzoquinoliziniums as activators of wild-type and mutant cystic fibrosis transmembrane conductance regulator channels. , 2004, Journal of medicinal chemistry.

[12]  A. Halayko,et al.  Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma , 2003, Respiratory Physiology & Neurobiology.

[13]  J. Clancy,et al.  A macromolecular complex of β2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Hong Yang,et al.  Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. , 2002, The Journal of clinical investigation.

[15]  M. Freichel,et al.  Functional interaction between TRP4 and CFTR in mouse aorta endothelial cells , 2001, BMC Physiology.

[16]  J. Lorenz,et al.  Chloride channel function is linked to epithelium-dependent airway relaxation. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[17]  M. Egan,et al.  CFTR is functionally active in GnRH-expressing GT1-7 hypothalamic neurons. , 1999, American journal of physiology. Cell physiology.

[18]  G. Shull,et al.  Ablation of the SERCA3 gene alters epithelium-dependent relaxation in mouse tracheal smooth muscle. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[19]  G. Shaw,et al.  Characterization of CFTR expression and chloride channel activity in human endothelia. , 1998, American journal of physiology. Cell physiology.

[20]  H. Magnussen,et al.  The relevance of resting tension to responsiveness and inherent tone of human bronchial smooth muscle , 1998, British journal of pharmacology.

[21]  A. Pavirani,et al.  Use of a membrane potential-sensitive probe to assess biological expression of the cystic fibrosis transmembrane conductance regulator. , 1995, Human gene therapy.

[22]  T. Omari,et al.  The epithelial barrier and airway responsiveness. , 1995, Canadian journal of physiology and pharmacology.

[23]  B. Horowitz,et al.  Expression of cystic fibrosis transmembrane regulator Cl- channels in heart. , 1992, Circulation research.

[24]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[25]  Y. Landry,et al.  Airway epithelium releases a relaxant factor: demonstration with substance P. , 1986, European journal of pharmacology.

[26]  N. Frossard,et al.  Epithelial modulation of tracheal smooth muscle response to antigenic stimulation. , 1986, Journal of applied physiology.

[27]  M. Corey,et al.  Bronchial hyperreactivity in cystic fibrosis and asthma. , 1978, The Journal of pediatrics.

[28]  B. Swynghedauw,et al.  Molecular mechanisms of myocardial remodeling. , 1999, Physiological reviews.

[29]  B D Schultz,et al.  Pharmacology of CFTR chloride channel activity. , 1999, Physiological reviews.

[30]  M. Welsh,et al.  Structure and function of the CFTR chloride channel. , 1999, Physiological reviews.

[31]  J. Pilewski,et al.  Role of CFTR in airway disease. , 1999, Physiological reviews.

[32]  G. Nagel,et al.  The CFTR chloride channel of mammalian heart. , 1995, Annual review of physiology.

[33]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.